pentetic acid has been researched along with Peritoneal Diseases in 2 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Peritoneal Diseases: Pathological processes involving the PERITONEUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A specific dose-response (P = 0." | 1.32 | Targeting of HER2 antigen for the treatment of disseminated peritoneal disease. ( Abdulla, A; Albert, PS; Brady, ED; Brechbiel, MW; Garmestani, K; Ma, D; Milenic, DE, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Milenic, DE | 1 |
| Garmestani, K | 1 |
| Brady, ED | 1 |
| Albert, PS | 1 |
| Ma, D | 1 |
| Abdulla, A | 1 |
| Brechbiel, MW | 1 |
| Low, RN | 1 |
| Sigeti, JS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase 0 Trial of (111)Indium CHX-A DTPA Trastuzumab Imaging in Cancer[NCT01445054] | Early Phase 1 | 13 participants (Actual) | Interventional | 2007-03-01 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for pentetic acid and Peritoneal Diseases
| Article | Year |
|---|---|
Targeting of HER2 antigen for the treatment of disseminated peritoneal disease.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colonic Neoplasms; Female; Human | 2004 |
MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Topics: Adult; Aged; Aged, 80 and over; Ascites; Contrast Media; Drug Combinations; False Positive Reactions | 1994 |